This article was produced by Sludge, an independent, ad-free investigative news site covering money in politics. Click here to support Sludge.
In 2021, as Americans consumed record amounts of vaccines and other pharmaceuticals, the drug industry’s chief lobbying group surpassed $609 million in revenues, according to tax documents obtained by Sludge.
The Pharmaceutical Research and Manufacturers of America’s (PhRMA) $609 million in revenue in 2021 is a new record for the group, which has been rapidly growing in recent years. In its 2020 filing, it reported revenue of $573 million. Its revenue has more than doubled in the past five years.
In 2021, PhRMA also spent more money than ever on lobbying the federal government, reporting to Congress expenditures of more than $29.3 million. Combined with political expenditures, PhRMA’s 2021 tax filing says it spent more than $205 million on non-deductible lobbying. This sum includes amounts spent on influencing legislation, intervening in political campaigns, communicating with government officials, or attempting to influence the general public. PhRMA spent more on federal lobbying in 2021 than just two other organizations, according to OpenSecrets.
Americans’ use of medicines has steadily grown over the years. According to research by IQVIA Institute, the use of medicines in the U.S. grew by 9.6% over the last five years. Overall, spending on U.S. medicines rose by 12% in 2021, primarily due to COVID-19 vaccines and therapies, according to IQVIA.
PhRMA represents 33 American and multinational drug companies, including the largest ones like Pfizer, Johnson & Johnson, AbbVie, and Merck. Its chief executive office since 2015, Stephen Ubl, was paid more than $6.1 million in 2021, according to the tax filing.
One of PhRMA’s chief aims in 2021 was to kill a proposal that congressional Democrats had been pushing in recent years to allow Medicare to negotiate with drug companies for lower prices and require drug companies to make the lower negotiated prices available to all buyers, including private insurance companies. That proposal sat in Congress as H.R.3, which is by far the most-named bill in PhRMA’s 2021 lobbying disclosures. While it has been largely successful at suppressing that legislation, some remnants of it were included in the Inflation Reduction Act, and starting in 2026 the government will be required to begin negotiating on prices of a small number of drugs, though many categories of drugs are exempt and the lower prices will not be available outside of Medicare.
PhRMA’s 2021 tax filing includes dozens of pages of grants and contributions it paid to other organizations over the year. Many of the payments went to patient advocacy groups, a type of arrangement that has often been pointed to as a corrupting factor in these groups’ missions to look after vulnerable patients.
Its largest grant was $11.7 million paid to We Work For Health, an advocacy and communications project created by PhRMA and its member companies that describes itself as “a grassroots initiative that shows how biopharmaceutical research and medical innovation work together.” According to a document from SevenTwenty Strategies, which developed and operates the project, We Work For Health is PhRMA’s first initiative designed to engage its member companies’ employees to help in its advocacy. The group has 15 state chapters and has expanded its coalition to include other business groups, labor unions, and more. The SevenTwenty Strategies document says that We Work For Health has registered approximately 10,000 activists for online engagement and has generated more than 25,000 communications to lawmakers.
Another large contribution made by PhRMA in 2021 was a $1.7 million donation to Center Forward, which is a nonprofit tied to the conservative Blue Dog Caucus of Democrats that has multiple PhRMA lobbyists on its board of directors. Center Forward also operates a super PAC that in the 2022 election cycle spent millions of dollars on ads supporting conservative Democratic candidates and opposing progressive Democrats and Republicans.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.